| Open Document File Size: 220,55 KBShare Result on Facebook
Company Sanofi Pasteur Inc. / / Country United States / / Facility Mycobacteriology laboratory / / IndustryTerm treatment for TB infection or disease / / MedicalCondition loss of consciousness / scar / immediate allergic reactions / allergic reaction / anaphylactic shock / necrosis / Presyncope / TB / bleb / M. tuberculosis / mumps / disease / Nervous system disorders / yellow fever / strain / Mycobacterium tuberculosis / tuberculous infection / measles / CARCINOGENESIS / chronic renal failure / eczema / anaphylaxis / acquired immunodeficiency syndrome / carcinoma / lymphomas / erythema / Allergy / Syncope / TB infection / tuberculosis infection / active disease / rubella / injury / delayed hypersensitivity / diabetes mellitus / Allergic reactions / oral polio / silicosis / AIDS / leukemias / burns / Hypersensitivity / anaphylactic reactions / infection / natural mycobacterial infection / documented active tuberculosis / M tuberculosis / pruritus / rash / varicella / disorders / tuberculosis / / MedicalTreatment immunization / vaccination / jejunoileal bypass / organ transplants / / Organization Food and Drug Administration / US Public Health Service / FDA / Centers for Disease Control and Prevention / / Person Tuberculin Purified Protein Derivative / / / Position physician / General / / Product Epinephrine / prednisone / / RadioStation 101 When / / URL http /
SocialTag |
sanofi pasteur[removed]TUBERSOL® 1 2